First-in-human dose-escalating trial of E. coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors. Chung, T., Rosenthal, E., Parker, W. B., Allan, P., Clemons, L., Lowman, D., Hong, J., Hunt, F. R., Richman, J., Conry, R., Mannion, K., Carroll, W., Nabell, L., Sorscher, E. J. AMER SOC CLINICAL ONCOLOGY. 2015

View details for Web of Science ID 000358036900717